Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Stocks to Watch: Samsung, Pepsi, TSMC -- WSJ

Stocks to Watch: Samsung, Pepsi, TSMC -- WSJ

Dow JonesDow Jones2026/10/08 13:55

By WSJ Staff Samsung Electronics (KR:005930): The Korean chip company said it expects its operating profit for this quarter to be more than double what it made for all of 2025. Still, shares fell, showing how lofty expectations from AI beneficiaries have become. Chip stocks including Micron (MU), Nvidia (NVDA) and Intel (INTC) also slipped in the U.S. Taiwan Semiconductor Manufacturing (TSM, TW:2330): The chip giant's September sales rose 55% on year, but they were down 0.6% from the previous month. Its U.S.-listed ADRs slipped. PepsiCo (PEP): The snacks and soda maker cut its earnings outlook for the year but said it saw improvement in its underperforming North American business; shares rose. Pacira BioSciences (PCRX): Shares in the pain-drug maker surged after Viatris (VTRS) agreed to buy it for $1.65 billion. This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage). (END) Dow Jones Newswires October 08, 2026 09:55 ET (13:55 GMT)

By WSJ Staff

Samsung Electronics (KR:005930): The Korean chip company said it expects its operating profit for this quarter to be more than double what it made for all of 2025. Still, shares fell, showing how lofty expectations from AI beneficiaries have become.

Chip stocks including Micron (MU), Nvidia (NVDA) and Intel (INTC) also slipped in the U.S.

Taiwan Semiconductor Manufacturing (TSM, TW:2330): The chip giant's September sales rose 55% on year, but they were down 0.6% from the previous month. Its U.S.-listed ADRs slipped.

PepsiCo (PEP): The snacks and soda maker cut its earnings outlook for the year but said it saw improvement in its underperforming North American business; shares rose.

Pacira BioSciences (PCRX): Shares in the pain-drug maker surged after Viatris (VTRS) agreed to buy it for $1.65 billion.

This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).

(END) Dow Jones Newswires

October 08, 2026 09:55 ET (13:55 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials

Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.

智通财经•2026/10/10 06:21